Advertisement
Advertisement

ERNA

ERNA logo

Ernexa Therapeutics Inc. Common Stock

4.53
USD
Sponsored
+0.32
+7.60%
Aug 10, 15:59 UTC -4
Closed
exchange

After-Market

4.46

-0.07
-1.46%

Ernexa Therapeutics Inc. Common Stock Profile

About

Ernexa Therapeutics is developing cell therapies for the treatment of advanced cancer and autoimmune disease. Ernexa Therapeutics, formerly known as Eterna Therapeutics, is based in CAMBRIDGE, Mass.

Info & Links

CEO

Sanjeev Luther

Headquarters

1035 CAMBRIDGE STREET, SUITE 18A
CAMBRIDGE, MA 02141, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.eternatx.com

Auditor

Haskell & White LLP

Share holders

121

Employees

5

Ernexa Therapeutics Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

5.21M

Enterprise Value

178.51K

Enterprise Value/EBITDA(ttm)

-0.02

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.53

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-305.93%

Return on Invested Capital(ttm)

-302.89%

Return on Assets(ttm)

-169.86%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-11.47M

Net Income Available to Common(ttm)

-12.27M

Diluted EPS(ttm)

-14.35

Share Statistics

Beta (5Y Monthly)

2.57

52-Week Change

-89.34%

S&P 500 52-Week Change

21.65%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

1.63M

Dividend Yield

0.00%

Float4

1.16M

% Held by Insiders

0.53%

% Held by Institutions

70.55%

Balance Sheet

Total Cash(mrq)

5.03M

Total Cash Per Share(mrq)

3.08

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.01%

Quick Ratio(mrq)

2.01%

Book Value Per Share(mrq)

2.73

Cash Flow

Operating Cash Flow Per Share(ytd)

-5.42

Free Cash Flow(ytd)

-6.42M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement